nonarteritic anterior ischemic optic neuropathy semaglutide linked to increased risk of vision loss in diabetes patients A recent VA study suggests

Follistatin is commonly referred to as an activin-binding protein

Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection

Weve seen this firsthand

Methods The current study involves the fusion of a native or mutant GLP-1 (30 residues) with an HSA-binding DARPin (123 residues) via a rigid helical linker (15 residues) to create fusion proteins (168 residues) resistant to DPP-IV and, or trypsin with extended half-lives using structural modeling, which are subsequently characterized using MD simulation and molecular docking analyses

most evidence comes from in vitro and animal models